UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 482

Sortiert nach

In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells

Nanomedicine, 2015-11, Vol.11 (8), p.2041-2050

2015

Link zum Volltext

Verfügbarkeit prüfen

The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria

Frontiers in pharmacology, 2022-08, Vol.13, p.957690-957690

2022

Link zum Volltext

Verfügbarkeit prüfen

The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems

Pharmaceutics, 2023-04, Vol.15 (4), p.1293

2023

Link zum Volltext

Verfügbarkeit prüfen

The Development of Dermal Self-Double-Emulsifying Drug Delivery Systems: Preformulation Studies as the Keys to Success

Pharmaceuticals (Basel, Switzerland), 2023-09, Vol.16 (10), p.1348

2023

Link zum Volltext

Verfügbarkeit prüfen

An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives

Frontiers in pharmacology, 2019-02, Vol.10, p.120

2019

Link zum Volltext

Verfügbarkeit prüfen

Recent progress in the development of anti-malarial quinolones

Malaria journal, 2014-08, Vol.13 (1), p.339-339, Article 339

2014

Link zum Volltext

Verfügbarkeit prüfen

Accumulation of TB-Active Compounds in Murine Organs Relevant to Infection by Mycobacterium tuberculosis

Frontiers in pharmacology, 2020-05, Vol.11, p.724-724

2020

Link zum Volltext

Verfügbarkeit prüfen

Anticancer properties of distinct antimalarial drug classes

PloS one, 2013-12, Vol.8 (12), p.e82962

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Activity of Decoquinate and Its Quinoline- O -Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts

Molecules (Basel, Switzerland), 2021-10, Vol.26 (21), p.6393

2021

Link zum Volltext

Verfügbarkeit prüfen

Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems

Antibiotics (Basel), 2022-06, Vol.11 (6), p.806

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins

Frontiers in pharmacology, 2024-01, Vol.14, p.1308400-1308400

2024

Link zum Volltext

Verfügbarkeit prüfen

The Case for Development of 11-Aza-artemisinins for Malaria

Current medicinal chemistry, 2015-01, Vol.22 (31), p.3607

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline- O -Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites

Pathogens (Basel), 2023-03, Vol.12 (3), p.447

2023

Link zum Volltext

Verfügbarkeit prüfen

A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)

Pharmaceuticals (Basel, Switzerland), 2021-09, Vol.14 (10), p.954

2021

Link zum Volltext

Verfügbarkeit prüfen

Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria

PloS one, 2013-08, Vol.8 (8), p.e72722

2013

Link zum Volltext

Verfügbarkeit prüfen

Artemisone and Artemiside Control Acute and Reactivated Toxoplasmosis in a Murine Model

Antimicrobial Agents and Chemotherapy, 2009-10, Vol.53 (10), p.4450-4456

2009

Link zum Volltext

Verfügbarkeit prüfen

Facile Preparation of N -Glycosylated 10-Piperazinyl Artemisinin Derivatives and Evaluation of Their Antimalarial and Cytotoxic Activities

Molecules (Basel, Switzerland), 2018-07, Vol.23 (7), p.1713

2018

Link zum Volltext

Verfügbarkeit prüfen

Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs

Frontiers in pharmacology, 2020-09, Vol.11, p.558894-558894

2020

Link zum Volltext

Verfügbarkeit prüfen

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue

Frontiers in pharmacology, 2022-09, Vol.13, p.988748-988748

2022

Link zum Volltext

Verfügbarkeit prüfen

Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle

Toxicology (Amsterdam), 2012-10, Vol.300 (1), p.57-66

2012

Link zum Volltext

Verfügbarkeit prüfen

Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro Growth

Antimicrobial Agents and Chemotherapy, 2007-05, Vol.51 (5), p.1852-1854

2007

Link zum Volltext

Verfügbarkeit prüfen

Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation

International journal for parasitology -- drugs and drug resistance, 2023-04, Vol.21, p.1-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System

Methods and protocols, 2023-11, Vol.6 (6), p.104

2023

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of the Arylaminoartemisinin GC012 against Helicobacter pylori and Its Effects on Biofilm

Pathogens (Basel), 2022-06, Vol.11 (7), p.740

2022

Link zum Volltext

Verfügbarkeit prüfen

Expression in Yeast Links Field Polymorphisms in PfATP6 to in Vitro Artemisinin Resistance and Identifies New Inhibitor Classes

The Journal of infectious diseases, 2013-08, Vol.208 (3), p.468-478

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 482

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(432)
Mit Volltextzugriff
(445)

Publikationsform

Sprache

Englisch
(474)
Japanisch
(87)
Deutsch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells

The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria

The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems

The Development of Dermal Self-Double-Emulsifying Drug Delivery Systems: Preformulation Studies as the Keys to Success

An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives

Recent progress in the development of anti-malarial quinolones

Accumulation of TB-Active Compounds in Murine Organs Relevant to Infection by Mycobacterium tuberculosis

Anticancer properties of distinct antimalarial drug classes

Assessment of the Activity of Decoquinate and Its Quinoline- O -Carbamate Derivatives against Toxoplasma gondii In Vitro and in Pregnant Mice Infected with T. gondii Oocysts

Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems

Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins

The Case for Development of 11-Aza-artemisinins for Malaria

In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline- O -Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites

A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)

Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria

Artemisone and Artemiside Control Acute and Reactivated Toxoplasmosis in a Murine Model

Facile Preparation of N -Glycosylated 10-Piperazinyl Artemisinin Derivatives and Evaluation of Their Antimalarial and Cytotoxic Activities

Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue

Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle

Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro Growth

Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation

Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System

In Vitro Activity of the Arylaminoartemisinin GC012 against Helicobacter pylori and Its Effects on Biofilm

Expression in Yeast Links Field Polymorphisms in PfATP6 to in Vitro Artemisinin Resistance and Identifies New Inhibitor Classes

Suchergebnisse filtern